Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,700 | 2,380 | 1,040 | -3,477 | N/A |
| Depreciation Amortization | 5,350 | 3,260 | 1,620 | 6,922 | N/A |
| Other Working Capital | -7,270 | -5,790 | -3,940 | -9,738 | N/A |
| Other Operating Activity | 210 | 210 | 90 | 4,900 | 0 |
| Operating Cash Flow | $990 | $60 | $-1,190 | $-1,393 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,620 | -4,680 | -2,370 | -9,689 | N/A |
| Net Acquisitions | 0 | 10,110 | 0 | 0 | N/A |
| Other Investing Activity | 12,010 | 0 | 3,770 | 4,914 | 0 |
| Investing Cash Flow | $4,390 | $5,430 | $1,400 | $-4,775 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -1,590 | -1,840 | -2,040 | 339 | 0 |
| Financing Cash Flow | $-1,590 | $-1,840 | $-2,040 | $339 | $N/A |
| Beginning Cash Position | 7,640 | 7,640 | 7,640 | 13,475 | N/A |
| End Cash Position | 11,430 | 11,300 | 5,810 | 7,646 | N/A |
| Net Cash Flow | $3,790 | $3,650 | $-1,820 | $-5,829 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 990 | 60 | -1,190 | -1,393 | N/A |
| Free Cash Flow | 990 | 60 | -1,190 | -1,393 | 0 |